A medicinal chemistry scientist turned patent attorney, Dr. Eifion Phillips has helped secure his clients’ intellectual property portfolios across various fields and innovations, including those pertaining to small and large molecule pharmaceuticals, drug formulation and delivery, methods of treatment, biochemical processes and manufacturing. He previously worked at Omeros Corporation, serving…...
Franklin Salisbury, Jr.
Franklin Salisbury, Jr. has a background in economics, law and religion. Trained in resource economics at Yale, he has spent his career fostering innovative collaborations with experts in different fields so they might work together to address and solve acute social, healthcare and environmental issues. Bachelors of Economics, Yale University…...
Rose Wang, M.B.A.
Rose Wang is a mission-driven entrepreneurial leader. She is the Founder & CEO of 1104Health, a digital health company working at the intersection of technology, healthcare and life sciences industries, leveraging AI and automation to bring cancer patients equitable access to precision oncology innovations globally. Ms. Wang is a serial…...
Pamela D. Garzone, Ph.D.
Pamela D. Garzone is a respected pharmaceutical executive with a significant record of achievement in drug development and leadership, ascending to the level of Chief Medical Officer. She has led teams successfully through the regulatory process, culminating in the clearance of multiple INDs in different therapeutic areas and approval of…...
Mien-Chie Hung, Ph.D.
Mien-Chie Hung received undergraduate and graduate degrees from National Taiwan University and his Ph.D. from Brandeis University. After completing postdoctoral training with Dr. Robert A. Weinberg at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology, Dr. Hung was recruited to the University of Texas’s MD Anderson…...
Scott Lippman, M.D.
Scott M. Lippman, M.D., is director of Moores Cancer Center at UC San Diego Health, professor of Medicine at UC San Diego School of Medicine, senior associate dean and associate vice chancellor for Cancer Research and Care and holds the Chugai Pharmaceutical Chair in Cancer. He is also an adjunct…...
Fei Shen, Ph.D.
Fei is an Investment Director in the Boehringer Ingelheim Corporate Venture Fund. She joined the Boehringer Ingelheim Venture Fund in 2020 and is located in Boston, MA. Fei received her Ph.D. in Neuropharmacology from Loyola University Chicago Stritch School of Medicine and a B.Sc in Biochemistry from East China University…...
Aleksandra Filipovic, M.D., Ph.D.
Aleksandra Filipovic MD, PhD, is head of oncology at PureTech, where she manages Oncology Asset Sourcing, review of oncology/ immuno oncology technologies and platforms from academia world-wide as well as biotech assets and pipelines amenable for commercialization and partnership. She is also responsible for pre-clinical and clinical development of therapeutics,…...
Dimitra Georganopoulou, Ph.D.
Dimitra currently serves on the Innovation Faculty of MIT linQ CATALYST. In this capaticy she mentors and guides innovators to accelerate and heighten the impact of their solutions on serious health and medical challenges. Dimitra was responsible for assessing and promoting inventions generated at Northwestern University as the Innovation and…...
